Showing results (1061-1070 of 1,917) with videos related to
Sort By:
Pageof 192
Medgenmed : Medscape General Medicine|August 24, 2006
A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical careMichael J Kozal, K Rivet Amico, Jennifer Chiarella, et al.Pediatrics|April 6, 2006
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescentsMichael E Pichichero, Mark M Blatter, William A Kennedy, et al.Pediatric Blood & Cancer|March 18, 2026
Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF-Fused Chiasmatic GliomaHelen Toledano, Alexander Yelak, Walid Kaadan, et al.Human Vaccines & Immunotherapeutics|February 21, 2019
Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physiciansMichelle McNamara, Philip O Buck, Songkai Yan, et al.Journal of Chemotherapy (Florence, Italy)|March 31, 2015
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)David J Guervil, Keith S Kaye, Ali Hassoun, et al.AIDS (London, England)|July 1, 1990
Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contactG Friedland, P Kahl, B Saltzman, et al.Journal of Orthopaedics|July 21, 2016
Variability in orthopedic surgeon treatment preferences for nondisplaced scaphoid fractures: A cross-sectional surveyMegan Carroll Paulus, Jake Braunstein, Daniel Merenstein, et al.Annals of Surgery|April 1, 1986
Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic diseaseW J Hodgson, M Friedland, T Ahmed, et al.Therapeutics and Clinical Risk Management|April 22, 2015
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unitChristy Maggiore, Jose A Vazquez, David J Guervil, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2004
A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited settingChristopher Jack, Umesh Lalloo, Quarraisha Abdool Karim, et al.Pageof 192